Tandem Diabetes Care (TNDM) Change in Accured Expenses (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Change in Accured Expenses came in at -$14.7 million in Q1 2026, down 7.55% YoY from -$15.9 million in Q1 2025, and down 1612.31% on a QoQ basis from -$861000.0 in Q4 2025.
Tandem Diabetes Care (TNDM) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Change in Accured Expenses data on file, last reported at -$14.7 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 7.55% year-over-year to -$14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 119.3% YoY) and the FY2025 annual result came in at -$664000.0, down 103.18% from the prior year.
- Change in Accured Expenses fell to -$14.7 million in Q1 2026, from -$861000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $15.8 million in Q3 2024 to a low of -$40.9 million in Q4 2022.
- A 5-year average of -$287058.8 and a median of $1.1 million in 2025 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses soared 946.05% — and 2025, when it plunged 728.78%.
- Tracing TNDM's Change in Accured Expenses over 5 years: stood at -$40.9 million in 2022, then jumped by 117.38% to $7.1 million in 2023, then decreased by 21.83% to $5.6 million in 2024, then sank by 115.49% to -$861000.0 in 2025, then tumbled by 1612.31% to -$14.7 million in 2026.
- The last three Change in Accured Expenses figures came in at -$14.7 million (Q1 2026), -$861000.0 (Q4 2025), and $12.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -2.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.33 Mn |
| Jun 30, 2026 | -2.33 Mn |
| Mar 31, 2026 | -14.74 Mn |
| Mar 31, 2026 | -14.74 Mn |
| Dec 31, 2025 | -861,000.00 |
| Dec 31, 2025 | -861,000.00 |
| Sep 30, 2025 | 12.85 Mn |
| Sep 30, 2025 | 12.85 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | -13.71 Mn |
| Mar 31, 2025 | -13.71 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Dec 31, 2024 | 5.56 Mn |
| Sep 30, 2024 | 15.76 Mn |
| Sep 30, 2024 | 15.76 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | -1.65 Mn |
| Mar 31, 2024 | -1.65 Mn |